About this FactMed analysis covering adverse side effect reports of ALIZAPRIDE patients who developed FALL.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 4 individuals taking ALIZAPRIDE reported FALL to the FDA. A total of 102 ALIZAPRIDE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ALIZAPRIDE and FALL. In doing so, we compare ALIZAPRIDE with other drugs that cause FALL, to help you evaluate whether or not ALIZAPRIDE causes FALL. Likewise, this page shows the most highly-reported side effects of ALIZAPRIDE, so you can see if FALL ranks among ALIZAPRIDE's most well-known side effects.
Summary Statistics
Reports of ALIZAPRIDE causing FALL: 4
Reports of any side effect of ALIZAPRIDE : 102
Percentage of ALIZAPRIDE patients where FALL is a reported side effect: 3.9216%

FDA reports of any drug causing FALL : 96231
Average percentage for all medicated patients where FALL is reported as a complication: 0.6031%

Physician opinion on ALIZAPRIDE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ALIZAPRIDE:
DRUG USE FOR UNKNOWN INDICATION ( 14 patients )
NAUSEA ( 14 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 3 patients )
PREMEDICATION ( 2 patients )
VOMITING ( 2 patients )
ANTIEMETIC SUPPORTIVE CARE ( 2 patients )
PROPHYLAXIS ( 1 patients )
PROPHYLAXIS OF NAUSEA AND VOMITING ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with FALL:

FOSAMAX (21241 patients)
FORTEO (10645 patients)
AVONEX (9614 patients)
ASPIRIN (8492 patients)
TYSABRI (6333 patients)
VIOXX (5874 patients)
SEROQUEL (3989 patients)
LASIX (3815 patients)
LIPITOR (3765 patients)
NEXIUM (3646 patients)
LYRICA (3421 patients)
SYNTHROID (3306 patients)
ZOMETA (3245 patients)
COUMADIN (3241 patients)
PREDNISONE (3147 patients)
LISINOPRIL (3143 patients)
NEURONTIN (3080 patients)
ALENDRONATE SODIUM (2879 patients)
HUMIRA (2761 patients)
FUROSEMIDE (2740 patients)
VITAMIN D (2726 patients)
SIMVASTATIN (2711 patients)
OMEPRAZOLE (2689 patients)
ATENOLOL (2605 patients)
PLAVIX (2560 patients)
XANAX (2542 patients)
CYMBALTA (2539 patients)
AMBIEN (2516 patients)
FOLIC ACID (2385 patients)
ZOLOFT (2380 patients)
ENBREL (2361 patients)
DIGOXIN (2267 patients)
PRILOSEC (2210 patients)
FOSAMAX PLUS D (2198 patients)
HYDROCHLOROTHIAZIDE (2156 patients)
REBIF (2150 patients)
METHOTREXATE (2147 patients)
CELEBREX (2131 patients)
ZOCOR (2108 patients)
LEVOTHYROXINE SODIUM (2092 patients)
REMICADE (2019 patients)
OXYCONTIN (1990 patients)
CALCIUM (1961 patients)
AREDIA (1952 patients)
ACETAMINOPHEN (1950 patients)
PROTONIX (1922 patients)
NORVASC (1894 patients)
LORAZEPAM (1873 patients)
LEXAPRO (1843 patients)
VICODIN (1842 patients)
LANTUS (1802 patients)
POTASSIUM CHLORIDE (1780 patients)
DURAGESIC-100 (1722 patients)
SANDOSTATIN LAR (1705 patients)
GABAPENTIN (1691 patients)
WARFARIN SODIUM (1649 patients)
ACTONEL (1647 patients)
TOPROL-XL (1619 patients)
DIOVAN (1614 patients)
ALBUTEROL (1580 patients)
CRESTOR (1574 patients)
CALCIUM (UNSPECIFIED) (1539 patients)
EFFEXOR (1519 patients)
PAXIL (1501 patients)
CLONAZEPAM (1497 patients)
PREMARIN (1495 patients)
PREVACID (1490 patients)
PERCOCET (1475 patients)
METFORMIN HCL (1472 patients)
PROZAC (1387 patients)
BONIVA (1381 patients)
ATIVAN (1349 patients)
ALLOPURINOL (1302 patients)
ZYPREXA (1299 patients)
METOPROLOL TARTRATE (1257 patients)
VITAMINS (UNSPECIFIED) (1256 patients)
LEVAQUIN (1244 patients)
REVLIMID (1224 patients)
IBUPROFEN (1219 patients)
CALCIUM CARBONATE (1216 patients)
ADVAIR DISKUS 100/50 (1205 patients)
CLOZARIL (1192 patients)
RISPERDAL (1175 patients)
AMLODIPINE (1165 patients)
DIAZEPAM (1164 patients)
BACLOFEN (1159 patients)
MULTI-VITAMIN (1150 patients)
KLONOPIN (1149 patients)
INSULIN (1136 patients)
ALPRAZOLAM (1130 patients)
BETASERON (1130 patients)
CELEXA (1100 patients)
CITALOPRAM HYDROBROMIDE (1093 patients)
TRAMADOL HCL (1089 patients)
ASCORBIC ACID (1087 patients)
BYETTA (1085 patients)
OXYCODONE HCL (1085 patients)
HUMALOG (1082 patients)
DEXAMETHASONE (1078 patients)
PREDNISONE TAB (1060 patients)
COREG (1057 patients)
VITAMIN E (1029 patients)
MORPHINE (1025 patients)
VALIUM (1015 patients)
NITROGLYCERIN (1013 patients)
MULTI-VITAMINS (1007 patients)
DIANEAL (998 patients)
SPIRONOLACTONE (972 patients)
ZANTAC (966 patients)
WELLBUTRIN (958 patients)
LORTAB (957 patients)
SPIRIVA (952 patients)
SINGULAIR (949 patients)
VITAMIN D (UNSPECIFIED) (946 patients)
TRAZODONE HCL (944 patients)
PREDNISOLONE (941 patients)
CHANTIX (940 patients)
EXELON (938 patients)
ZYRTEC (937 patients)
ZOLEDRONOC ACID (933 patients)
RAMIPRIL (927 patients)
ZOFRAN (894 patients)
METOPROLOL (891 patients)
FLEXERIL (883 patients)
GLUCOPHAGE (879 patients)
EVISTA (874 patients)
ARICEPT (873 patients)
[THERAPY UNSPECIFIED] (871 patients)
FENTANYL (866 patients)
NAMENDA (850 patients)
COZAAR (846 patients)
ACTOS (834 patients)
VITAMIN B-12 (818 patients)
ALLEGRA (816 patients)
ENALAPRIL MALEATE (806 patients)
TEGRETOL (804 patients)
FLOMAX (796 patients)
DECADRON (795 patients)
PRADAXA (784 patients)
TYLENOL (CAPLET) (775 patients)
AMITRIPTYLINE HCL (760 patients)
ZETIA (759 patients)
AMOXICILLIN (756 patients)
LOVENOX (753 patients)
KEPPRA (752 patients)
COLACE (751 patients)
EFFEXOR XR (741 patients)
LAMICTAL (724 patients)
ELAVIL (713 patients)
ALDACTONE (708 patients)
FISH OIL (706 patients)
HYDROCODONE (706 patients)
DEPAKOTE (705 patients)
ULTRAM (703 patients)
EXJADE (691 patients)
DILAUDID (687 patients)
DILANTIN (682 patients)
ARIMIDEX (682 patients)
GLIPIZIDE (681 patients)
AVANDIA (678 patients)
LANSOPRAZOLE (672 patients)
REGLAN (671 patients)
LOPRESSOR (670 patients)
POTASSIUM (668 patients)
GLYBURIDE (663 patients)
MIRTAZAPINE (661 patients)
CLONIDINE (655 patients)
FEMARA (653 patients)
HYDROCODONE BITARTRATE (645 patients)
TRACLEER (644 patients)
TEMAZEPAM (643 patients)
BENADRYL (642 patients)
TYLENOL (642 patients)
TOPAMAX (632 patients)
METFORMIN (632 patients)
ALTACE (630 patients)
MORPHINE SULFATE (627 patients)
FERROUS SULFATE TAB (617 patients)
RANITIDINE (610 patients)
COMPAZINE (609 patients)
HEPARIN SODIUM INJECTION (605 patients)
CIPROFLOXACIN (604 patients)
VELCADE (599 patients)
FLONASE (590 patients)
CLOZAPINE (589 patients)
PEPCID (586 patients)
LEVOXYL (582 patients)
SOMA (582 patients)
TAMOXIFEN CITRATE (573 patients)
PROVIGIL (571 patients)
CARVEDILOL (569 patients)
NAPROXEN (569 patients)
RECLAST (568 patients)
METOPROLOL SUCCINATE (561 patients)
FLUOXETINE (557 patients)
AMARYL (552 patients)
KLOR-CON (551 patients)
ZOLPIDEM (546 patients)
PANTOPRAZOLE (542 patients)
CEPHALEXIN (540 patients)
CLARITIN (540 patients)
CHEMOTHERAPEUTICS NOS (534 patients)
ARANESP (531 patients)
SINEMET (528 patients)
ACIPHEX (526 patients)
REQUIP (524 patients)
VERAPAMIL (521 patients)
PROMETHAZINE (521 patients)
BISOPROLOL FUMARATE (520 patients)
IRON (519 patients)
Most common side effects for patients taking ALIZAPRIDE:
DIARRHOEA (16 patients)
PYREXIA (16 patients)
VOMITING (10 patients)
FATIGUE (9 patients)
HYPOKALAEMIA (9 patients)
DEHYDRATION (8 patients)
NAUSEA (7 patients)
ANAEMIA (6 patients)
ASTHENIA (6 patients)
BRONCHOPNEUMONIA (6 patients)
DRUG INTERACTION (6 patients)
DYSPNOEA (6 patients)
HYPOTENSION (6 patients)
PNEUMONIA (6 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (5 patients)
HAEMORRHAGE (5 patients)
HYPOMAGNESAEMIA (5 patients)
HYPOPHOSPHATAEMIA (5 patients)
JAUNDICE (5 patients)
RESPIRATORY FAILURE (5 patients)
SOMNOLENCE (5 patients)
TACHYCARDIA (5 patients)
ABDOMINAL PAIN (4 patients)
ADVERSE DRUG REACTION (4 patients)
FALL (4 patients)
HAEMODIALYSIS (4 patients)
HAEMOGLOBIN DECREASED (4 patients)
INTESTINAL OBSTRUCTION (4 patients)
MALAISE (4 patients)
SLEEP APNOEA SYNDROME (4 patients)
SUPRAVENTRICULAR TACHYCARDIA (4 patients)
THROMBOCYTHAEMIA (4 patients)
THROMBOCYTOPENIA (4 patients)
WHITE BLOOD CELL COUNT DECREASED (4 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (3 patients)
BACTERIAL SEPSIS (3 patients)
BLOOD BILIRUBIN INCREASED (3 patients)
BLOOD CREATININE INCREASED (3 patients)
DECREASED APPETITE (3 patients)
DERMATITIS EXFOLIATIVE (3 patients)
DEVICE DISLOCATION (3 patients)
ENTERITIS (3 patients)
FEBRILE NEUTROPENIA (3 patients)
FIBRIN D DIMER INCREASED (3 patients)
FUSOBACTERIUM INFECTION (3 patients)
HAEMOPTYSIS (3 patients)
HYPOXIA (3 patients)
ILEUS (3 patients)
LEUKAEMIA RECURRENT (3 patients)
MUCOSAL INFLAMMATION (3 patients)
NEUROTOXICITY (3 patients)
NEUTROPENIA (3 patients)
OVERDOSE (3 patients)
PRESYNCOPE (3 patients)
PROTEUS INFECTION (3 patients)
RASH (3 patients)
RENAL FAILURE ACUTE (3 patients)
SEPTIC SHOCK (3 patients)
SUPERINFECTION (3 patients)
TONGUE DISORDER (3 patients)
ACUTE PULMONARY OEDEMA (2 patients)
AGRANULOCYTOSIS (2 patients)
ATRIAL FIBRILLATION (2 patients)
BLOOD FIBRINOGEN INCREASED (2 patients)
BLOOD GLUCOSE INCREASED (2 patients)
BONE MARROW DEPRESSION (2 patients)
BONE MARROW FAILURE (2 patients)
BRONCHOPULMONARY ASPERGILLOSIS (2 patients)
C-REACTIVE PROTEIN INCREASED (2 patients)
CHILLS (2 patients)
COLITIS ISCHAEMIC (2 patients)
CONSTIPATION (2 patients)
CONVULSION (2 patients)
CORONARY ARTERY DISEASE (2 patients)
DEAFNESS (2 patients)
DIZZINESS (2 patients)
DRUG ADMINISTRATION ERROR (2 patients)
DYSPHAGIA (2 patients)
DYSURIA (2 patients)
EJECTION FRACTION DECREASED (2 patients)
ERYSIPELAS (2 patients)
FACIAL PALSY (2 patients)
FEBRILE BONE MARROW APLASIA (2 patients)
FLATULENCE (2 patients)
GASTROENTERITIS (2 patients)
HAEMATOCRIT DECREASED (2 patients)
HYPERSENSITIVITY (2 patients)
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION (2 patients)
INFECTION (2 patients)
KLEBSIELLA SEPSIS (2 patients)
LEUKOPENIA (2 patients)
LYMPHANGITIS (2 patients)
LYMPHOCYTE COUNT INCREASED (2 patients)
NERVOUS SYSTEM DISORDER (2 patients)
NEUTROPHIL COUNT DECREASED (2 patients)
OEDEMA MUCOSAL (2 patients)
OTITIS MEDIA (2 patients)
PANCYTOPENIA (2 patients)
PARTIAL SEIZURES (2 patients)
PLATELET COUNT DECREASED (2 patients)
PULMONARY EMBOLISM (2 patients)
RED BLOOD CELL COUNT DECREASED (2 patients)
RENAL FAILURE (2 patients)
RHINORRHOEA (2 patients)
SHOCK (2 patients)
STREPTOCOCCAL SEPSIS (2 patients)
SUDDEN CARDIAC DEATH (2 patients)
URTICARIA (2 patients)
ACCIDENTAL OVERDOSE (1 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE (1 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN (1 patients)
AGITATION (1 patients)
ALVEOLITIS (1 patients)
ANOREXIA (1 patients)
ANXIETY (1 patients)
APHASIA (1 patients)
APHTHOUS STOMATITIS (1 patients)
ARACHNOIDITIS (1 patients)
BLOOD CULTURE POSITIVE (1 patients)
CALCULUS URINARY (1 patients)
CANDIDA SEPSIS (1 patients)
CANDIDIASIS (1 patients)
CARDIO-RESPIRATORY ARREST (1 patients)
CENTRAL NERVOUS SYSTEM LEUKAEMIA (1 patients)
CEREBRAL HAEMORRHAGE (1 patients)
CHEST PAIN (1 patients)
COLITIS (1 patients)
CONFUSIONAL STATE (1 patients)
COUGH (1 patients)
CYANOSIS (1 patients)
DIARRHOEA INFECTIOUS (1 patients)
DISEASE PROGRESSION (1 patients)
DISLOCATION OF VERTEBRA (1 patients)
DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED DRUG (1 patients)
DRUG HYPERSENSITIVITY (1 patients)
DRUG TOXICITY (1 patients)
DRY SKIN (1 patients)
ENCEPHALOPATHY (1 patients)
EPILEPSY (1 patients)
ERYTHEMA (1 patients)
FLUSHING (1 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (1 patients)
GENERAL PHYSICAL CONDITION ABNORMAL (1 patients)
GRAFT VERSUS HOST DISEASE (1 patients)
HAEMATURIA (1 patients)
HEADACHE (1 patients)
HYPERBILIRUBINAEMIA (1 patients)
HYPERTENSIVE CRISIS (1 patients)
HYPOACUSIS (1 patients)
HYPOAESTHESIA (1 patients)
HYPOCALCAEMIA (1 patients)
HYPOMANIA (1 patients)
HYPOVOLAEMIC SHOCK (1 patients)
KLEBSIELLA INFECTION (1 patients)
LACTOSE INTOLERANCE (1 patients)
LEUKAEMIA PLASMACYTIC (1 patients)
METASTATIC NEOPLASM (1 patients)
MULTI-ORGAN FAILURE (1 patients)
MULTIPLE MYELOMA (1 patients)
MUSCULAR WEAKNESS (1 patients)
MYALGIA (1 patients)
MYOGLOBIN BLOOD INCREASED (1 patients)
NEOPLASM (1 patients)
NEURALGIA (1 patients)
OEDEMA (1 patients)
OEDEMA PERIPHERAL (1 patients)
PAIN (1 patients)
PARESIS (1 patients)
PNEUMONIA KLEBSIELLA (1 patients)
PNEUMONITIS (1 patients)
PRODUCTIVE COUGH (1 patients)
PRURITUS (1 patients)
PULMONARY ALVEOLAR HAEMORRHAGE (1 patients)
PULMONARY HYPERTENSION (1 patients)
RADIUS FRACTURE (1 patients)
RASH GENERALISED (1 patients)
RASH MACULAR (1 patients)
RASH MACULO-PAPULAR (1 patients)
RENAL COLIC (1 patients)
RESPIRATORY DISTRESS (1 patients)
RIGHT VENTRICULAR DYSFUNCTION (1 patients)
SEPSIS (1 patients)
SKIN LESION (1 patients)
SPUTUM PURULENT (1 patients)
STAPHYLOCOCCAL BACTERAEMIA (1 patients)
STEM CELL TRANSPLANT (1 patients)
STOMATITIS (1 patients)
THROMBOSIS (1 patients)
THROMBOTIC MICROANGIOPATHY (1 patients)
TOXICITY TO VARIOUS AGENTS (1 patients)
ULNA FRACTURE (1 patients)
WEIGHT DECREASED (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ALIZAPRIDE


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about FALL and ALIZAPRIDE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ALIZAPRIDE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ALIZAPRIDE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ALIZAPRIDE experts. If you are a healthcare provider experienced in prescribing ALIZAPRIDE, please register here.

Your online appointment book for York Rentals & Services

© 2014 FactMed, Inc
Privacy Policy
Terms of Use